Importantly, these NP-PTEN-mediated effects have been found to inhibit in vitro cell proliferation and induce apoptosis, as well as suppress the in vivo growth of tumor xenografts, indicating the anti-cancer efficacy and therapeutic potential of this gene therapy approach for NSCLC [74]. The gene discussed is PTEN; the disease is cancer.